Stockreport

BridgeBio Pharma’s Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing Capacity

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF The deal is designed to accelerate BridgeBio’s gene therapy programsThe dedicated suite will support clinical and commercial supply needs for BridgeBio’s gene therapy pr [Read more]